Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma

Critical Care Medicine

Volumn 37, Issue 6, 2009, Pages 1845-1849

  Castelli, Gian Paolo ^a   Pognani, Claudio ^a   Cita, Massimo ^a   Paladini, Rolando ^a  

^a Intensive Care Therapy and Pain Relief ^*  (Italy)

Author keywords

Injury Severity Score; Procalcitonin; Sepsis; Sequential Organ Failure Assessment score; Systemic inflammatory response syndrome; Trauma

Indexed keywords

C REACTIVE PROTEIN; LACTIC ACID; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INJURY; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SCORING SYSTEM; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; AGED; BLOOD; INJURY SCALE; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 66449093196     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819ffd5b     Document Type: Article

References (32)

1. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
2. Pittet D, Rangel-Frausto S, Li N, et al: Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995; 21: 302-309
3. Christ-Crain M, Muller B: Biomarkers in respiratory tract infections: Diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007; 30: 556-573
4. Al-Nawas B, Krammer I, Shah PM: Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996; 1:331-333
5. Benoist JF, Mimoz O, Assicot M, et al: Serum procalcitonin, but not C-reactive protein, identifies sepsis in trauma patients. Clin Chem 1998; 44(8 Pt 1):1778-1779
6. Castelli GP, Pognani C, Meisner M, et al: Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004; 8:R234-R242
7. Luzzani A, Polati E, Dorizzi R, et al: Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31:1737-1741
8. Matson A, Soni N, Sheldon J. C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care 1991; 19: 182-186
9. Meisner M, Adina H, Schmidt J: Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006; 10:R1
10. Muller B, Becker KL, Schachinger H, et al: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28:977-983
11. Povoa P, Almeida E, Moreira P, et al: C-reactive protein as an indicator of sepsis. Intensive Care Med 1998; 24:1052-1056
12. Ugarte H, Silva E, Mercan D, et al: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498-504
13. Yentis SM, Soni N, Sheldon J: C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995; 21:602-605
14. Jensen JU, Heslet L, Jensen TH, et al: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34:2596-2602
15. Meisner M, Tschaikowsky K, Palmaers T, et al: Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999; 3:45-50
16. Uzzan B, Cohen R, Nicolas P, et al: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006; 34:1996-2003
17. Hensler T, Sauerland S, Lefering R, et al: The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 2003; 20:420-426
18. Mimoz O, Benoist JF, Edouard AR, et al: Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24:185-188
19. Wanner GA, Keel M, Steckholzer U, et al: Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients [see comments]. Crit Care Med 2000; 28:950-957
20. Civil ID, Schwab CW: The Abbreviated Injury Scale, 1985 revision: A condensed chart for clinical use. J Trauma 1988; 28:87-90
21. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
22. Laffey JG, Boylan JF, Cheng DC: The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 2002; 97:215-252
23. Lin E, Calvano SE, Lowry SF: Inflammatory cytokines and cell response in surgery. Surgery 2000; 127:117-126
24. Meisner M, Tschaikowsky K, Hutzler A, et al: Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24:680-684
25. Sponholz C, Sakr Y, Reinhart K, et al: Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: A systematic review of the literature. Crit Care 2006; 10:R145
26. Franke A, Lante W, Kupser S, et al: Procalcitonin levels after different types of conventional thoracic surgery. Thorac Cardiovasc Surg 2008; 56:46-50
27. Pettila V, Hynninen M, Takkunen O, et al: Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28: 1220-1225
28. Lodise TP Jr, Patel N, Kwa A, et al: Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: Impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 2007; 51:3510-3515
29. Lodise TP, McKinnon PS, Swiderski L, et al: Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36:1418-1423
30. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
31. Jensen JU, Lundgren B, Hein L, et al: The Procalcitonin And Survival Study (PASS) - A randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker procalcitonin and proactive diagnostic and therapeutic responses to abnormal procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients. BMC Infect Dis 2008; 8:91
32. Harbarth S, Holeckova K, Froidevaux C, et al: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164:396-402